# Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)

> **NCT07113223** · NA · RECRUITING · sponsor: **Idoven 1903 S.L.** · enrollment: 1968 (estimated)

## Conditions studied

- Heart Failure
- Cardiovascular Risk Factors

## Interventions

- **DEVICE:** Willem™ platform ECG assessment

## Key facts

- **NCT ID:** NCT07113223
- **Lead sponsor:** Idoven 1903 S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-23
- **Primary completion:** 2026-07
- **Final completion:** 2026-09
- **Target enrollment:** 1968 (ESTIMATED)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07113223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07113223, "Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07113223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*